News about Global Pharma

Glenmark, Jiangsu Alphamab and 3D Medicines Sign Agreement for KN035 (Envafolimab) for Multiple Geographies

Glenmark Specialty S.A. (GSSA), a subsidiary of Glenmark Pharmaceuticals Ltd. (Glenmark) announced the signing of a license agreement with JIANGSU ALPHAMAB BIOPHARMACEUTICALS CO., LTD (Jiangsu Alphamab) and 3D MEDICINES INC. (3D Medicines), (together as the Licensors), for KN035 (Envafolimab) for India, Asia Pacific.

Global Pharma | 25/01/2024 | By Manvi |  755

MolecuLight Wins VA Contract for Advanced Wound Imaging Devices

This contract, facilitated through the VA FSS program, reinforces MolecuLight's commitment to addressing healthcare requirements for Veterans and other federal government agencies.

Global Pharma | 25/01/2024 | By Manvi |  267

SHL Medical, SteriPack Group Forms Partnership for Drug Delivery System Assembly Services

The collaboration aims to establish a pre-validated final assembly service at the SteriPack facility in Poland, offering enhanced flexibility in supply chain strategies for their customers.

Global Pharma | 24/01/2024 | By Manvi |  763

Seegene Announces Collaboration with Microsoft to Realize 'a World Free from All Diseases'

Seegene Inc. announced its selection of Microsoft as a technology partner for its SG OneSystemTM business in London, UK to realize 'a world free from all diseases.'

Global Pharma | 24/01/2024 | By Manvi |  528

Heron Therapeutics' ZYNRELEF Receives FDA Approval for Expanded Surgical Indication

The expanded indication covers soft tissue and orthopedic surgical procedures, including foot and ankle, and others avoiding direct exposure to articular cartilage.

Global Pharma | 24/01/2024 | By Manvi |  1008

Amadix's PreveCol Colorectal Cancer Screening Test Granted FDA Breakthrough Device Designation

This recognition positions Amadix as the first European company to achieve such status for early detection of colorectal cancer.

Global Pharma | 23/01/2024 | By Manvi |  748

Pharma Logistics Appoints David A. Hargraves as CEO

In response to the transition, Zaccaro expressed confidence in Hargraves' ability to lead Pharma Logistics into a future marked by growth and innovation.

Global Pharma | 23/01/2024 | By Manvi |  542

Sandoz to Bolster Ophthalmology Portfolio Through Acquisition of CIMERLI Biosimilar

The acquisition aligns with Sandoz's dedication to providing expanded treatment options for US patients dealing with vision impairment and loss.

Global Pharma | 22/01/2024 | By Manvi |  793

Progeria Research Foundation's Zokinvy Receives Approval in Japan for Progeria Treatment

PRF, a pioneering force in rare disease research, has been at the forefront of Zokinvy clinical trial research since 2007.

Global Pharma | 22/01/2024 | By Manvi |  598

Johnson & Johnson's BALVERSA Granted Full FDA Approval for Advanced Urothelial Carcinoma Treatment

This approval is specifically for patients whose disease has progressed after at least one prior systemic therapy, excluding those eligible for and not having received prior PD-1 or PD-L1 inhibitor therapy.

Global Pharma | 20/01/2024 | By Manvi |  995